Robert-Jan van Geuns

Author PubWeight™ 105.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005 2.93
2 Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 2011 2.85
3 Diagnostic accuracy and clinical utility of noninvasive testing for coronary artery disease. Ann Intern Med 2010 2.80
4 Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008 2.57
5 Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 2005 2.50
6 Assessment of the aortic annulus by multislice computed tomography, contrast aortography, and trans-thoracic echocardiography in patients referred for transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011 2.30
7 Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet 2012 2.14
8 Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur Radiol 2012 2.14
9 Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 2013 2.11
10 Efficient quantification of the left ventricular volume using 3-dimensional echocardiography: the minimal number of equiangular long-axis images for accurate quantification of the left ventricular volume. J Am Soc Echocardiogr 2007 1.93
11 Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial. Eur Heart J 2013 1.87
12 Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis 2011 1.84
13 Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J Mol Cell Cardiol 2007 1.61
14 Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010 1.54
15 The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005 1.51
16 Magnetic navigation system used successfully to cross a crushed stent in a bifurcation that failed with conventional wires. Catheter Cardiovasc Interv 2007 1.50
17 Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). J Am Coll Cardiol 2013 1.47
18 Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock. Cardiology 2012 1.46
19 Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv 2012 1.45
20 Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years. Catheter Cardiovasc Interv 2012 1.45
21 NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography. JACC Cardiovasc Imaging 2011 1.42
22 Validity and variability in visual assessment of stenosis severity in phantom bifurcation lesions: a survey in experts during the fifth meeting of the European Bifurcation Club. Catheter Cardiovasc Interv 2011 1.42
23 Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study. EuroIntervention 2015 1.40
24 Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. J Invasive Cardiol 2011 1.39
25 Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 2014 1.26
26 The influence of optimal medical treatment on the 'obesity paradox', body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open 2012 1.24
27 Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol 2006 1.24
28 First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv 2012 1.19
29 In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 2013 1.16
30 Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? Eur Heart J 2006 1.12
31 A comparison between QLAB and TomTec full volume reconstruction for real time three-dimensional echocardiographic quantification of left ventricular volumes. Echocardiography 2007 1.07
32 Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective. EuroIntervention 2015 1.04
33 Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol 2005 1.04
34 Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. J Am Coll Cardiol 2006 1.02
35 In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions. Catheter Cardiovasc Interv 2011 1.01
36 Quantification of left ventricular volumes and function in patients with cardiomyopathies by real-time three-dimensional echocardiography: a head-to-head comparison between two different semiautomated endocardial border detection algorithms. J Am Soc Echocardiogr 2007 1.01
37 Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages. EuroIntervention 2010 1.00
38 Quantitative computed tomographic coronary angiography: does it predict functionally significant coronary stenoses? Circ Cardiovasc Imaging 2013 1.00
39 Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart 2012 0.99
40 Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2005 0.99
41 A simplified continuity equation approach to the quantification of stenotic bicuspid aortic valves using velocity-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2007 0.95
42 Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013 0.95
43 Effect of experience on results of transcatheter aortic valve implantation using a Medtronic CoreValve System. Am J Cardiol 2011 0.93
44 Frequency, determinants and prognostic implications of infectious complications after transcatheter aortic valve implantation. Am J Cardiol 2013 0.92
45 True mitral annulus diameter is underestimated by two-dimensional echocardiography as evidenced by real-time three-dimensional echocardiography and magnetic resonance imaging. Int J Cardiovasc Imaging 2006 0.90
46 Quantification of myocardial blood flow by adenosine-stress CT perfusion imaging in pigs during various degrees of stenosis correlates well with coronary artery blood flow and fractional flow reserve. Eur Heart J Cardiovasc Imaging 2012 0.90
47 Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire - fractional flow reserve. EuroIntervention 2014 0.88
48 Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function. Am J Cardiol 2007 0.87
49 Cardiac CT: necessary for precise sizing for transcatheter aortic implantation. EuroIntervention 2010 0.87
50 Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application. EuroIntervention 2011 0.86
51 Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial. EuroIntervention 2015 0.86
52 Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. EuroIntervention 2011 0.86
53 Prosthesis-patient mismatch after transcatheter aortic valve implantation with the medtronic CoreValve system in patients with aortic stenosis. Am J Cardiol 2010 0.86
54 Three-dimensional coronary anatomy in contrast-enhanced multislice computed tomography. Prev Cardiol 2002 0.85
55 Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. EuroIntervention 2012 0.84
56 Health-related quality of life in the elderly three years after percutaneous coronary intervention. EuroIntervention 2013 0.84
57 The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3). EuroIntervention 2012 0.84
58 Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography. Arterioscler Thromb Vasc Biol 2014 0.84
59 Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv 2013 0.83
60 Advanced three-dimensional quantitative coronary angiographic assessment of bifurcation lesions: methodology and phantom validation. EuroIntervention 2013 0.83
61 Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study. Thromb Haemost 2014 0.82
62 Rapid exchange ultra-thin microcatheter using fibre-optic sensing technology for measurement of intracoronary fractional flow reserve. EuroIntervention 2015 0.81
63 Rapid and accurate measurement of left ventricular function with a new second-harmonic fast-rotating transducer and semi-automated border detection. Echocardiography 2006 0.80
64 Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol 2013 0.80
65 Traumatic coronary artery dissection: potential cause of sudden death in soccer. Circulation 2013 0.80
66 Ascending aorta dilatation in patients with bicuspid aortic valve stenosis: a prospective CMR study. Eur Radiol 2012 0.80
67 Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study. EuroIntervention 2011 0.80
68 TheTryton side branch stent. EuroIntervention 2010 0.80
69 Remote ischemic conditioning in percutaneous coronary intervention and coronary artery bypass grafting. Circ J 2012 0.80
70 One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry. EuroIntervention 2015 0.79
71 Trial participation as a determinant of clinical outcome: differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiology. Int J Cardiol 2013 0.79
72 Relative myocardial blood flow by dynamic computed tomographic perfusion imaging predicts hemodynamic significance of coronary stenosis better than absolute blood flow. Invest Radiol 2014 0.79
73 Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting? Circulation 2012 0.79
74 "Over-and-under" pericardial covered stent with paclitaxel balloon in a saphenous vein graft. Catheter Cardiovasc Interv 2010 0.79
75 Magnetic resonance assessment of left ventricular volumes and mass using a single-breath-hold 3D k-t BLAST cine b-SSFP in comparison with multiple-breath-hold 2D cine b-SSFP. Insights Imaging 2010 0.78
76 The emerging application of remote ischemic conditioning in the clinical arena. Cardiol Rev 2012 0.78
77 Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. EuroIntervention 2011 0.78
78 Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis. EuroIntervention 2011 0.78
79 Distance of lipid core-rich plaques from the ostium by NIRS in nonculprit coronary arteries. JACC Cardiovasc Imaging 2012 0.78
80 High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention. EuroIntervention 2016 0.78
81 Everolimus Eluting Bioresorbable Vascular Scaffold for Treatment of Complex Chronic Total Occlusions. EuroIntervention 2017 0.77
82 Perforation of the membranous interventricular septum after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2009 0.77
83 How should I treat an unusual referral for heart transplantation? EuroIntervention 2010 0.77
84 Evaluation of pericardial hydatid cysts by different echocardiographic imaging modalities. Int J Cardiovasc Imaging 2006 0.77
85 Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. EuroIntervention 2013 0.77
86 Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study. EuroIntervention 2014 0.77
87 Computed tomography as a tool for percutaneous coronary intervention of chronic total occlusions. EuroIntervention 2010 0.77
88 Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study. EuroIntervention 2011 0.77
89 Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery disease. JACC Cardiovasc Imaging 2012 0.77
90 Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study. EuroIntervention 2016 0.77
91 The feasibility and safety of applying the Magnetic Navigation System to manage chronically occluded vessels: a single centre experience. EuroIntervention 2011 0.76
92 Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report. Hellenic J Cardiol 2015 0.76
93 Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts. EuroIntervention 2010 0.76
94 Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome. Biomarkers 2014 0.76
95 Arguments for recanalization of chronic total occlusions. JACC Cardiovasc Interv 2008 0.76
96 Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial. EuroIntervention 2012 0.76
97 Noninvasive coronary imaging: the contest between magnetic resonance and computed tomographic coronary angiography. Circ Cardiovasc Imaging 2008 0.75
98 Response to letter regarding article, "Histopathology of embolic debris captured during transcatheter aortic valve replacement". Circulation 2013 0.75
99 Clinical outcomes with the STENTYS Self-Apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction 2-year insights from the APPOSTION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry. EuroIntervention 2017 0.75
100 One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study. J Invasive Cardiol 2017 0.75
101 Treatment of bioresorbable scaffold failure. EuroIntervention 2015 0.75
102 Automated characterisation of lipid core plaques in vivo by quantitative optical coherence tomography tissue type imaging. EuroIntervention 2016 0.75
103 The coronary Stent-On-A-Wire (SOAW). EuroIntervention 2010 0.75
104 Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease. EuroIntervention 2011 0.75
105 Qualitative and quantitative evaluation of dynamic changes in non-culprit coronary atherosclerotic lesion morphology. A longitudinal OCT study. EuroIntervention 2017 0.75
106 Bioresorbable vascular scaffold for ST elevation myocardial infarction: optical coherence tomography observations at the 2-year follow-up. Coron Artery Dis 2015 0.75
107 Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH). EuroIntervention 2014 0.75
108 Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model. EuroIntervention 2012 0.75
109 Magnetic navigation in patients with coronary artery bypass grafting. EuroIntervention 2009 0.75
110 Images in cardiovascular medicine. Multislice computed tomography for the evaluation and follow-up of stenting of aortic coarctation. Circulation 2004 0.75
111 Magnetic navigation system assisted stenting of coronary bifurcation lesions. EuroIntervention 2011 0.75
112 Essentials of quantitative angiography for bifurcation lesions. EuroIntervention 2010 0.75
113 Left ventricular angiogram in a patient with noncompaction cardiomyopathy. EuroIntervention 2007 0.75
114 Design and Principle of Operation of the HeartMate PHPTM (Percutaneous Heart Pump). EuroIntervention 2016 0.75
115 Why a EuroIntervention supplement on bifurcation stenting? EuroIntervention 2010 0.75
116 Temporal evolution of strut light intensity after implantation of bioresorbable polymeric intracoronary scaffolds in the ABSORB cohort B trial-an application of a new quantitative method based on optical coherence tomography. Circ J 2014 0.75
117 Serial quantitative magnetic resonance angiography follow-up of renal artery dimensions following treatment by four different renal denervation systems. EuroIntervention 2017 0.75
118 Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease). EuroIntervention 2015 0.75